Where can I buy ianthus capital shares?
Shares of ITHUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is iAnthus Capital's stock price today?
What is the ianthus recapitalization transaction?
iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, provides an update with respect to the Company's previously announced recapitalization transaction (the "Recapitalization Transaction").
What does a hold rating on ianthus capital mean?
A hold rating indicates that analysts believe investors should maintain any existing positions they have in IAN, but not buy additional shares or sell existing shares. View analyst ratings for iAnthus Capital or view top-rated stocks. When is iAnthus Capital's next earnings date?
How do I buy shares of Ian?
Shares of IAN and other Canadian stocks can be purchased through an online brokerage account.
Is Ianthus stock a good buy?
Is Ianthus Capital Holdings Inc stock A Buy? Ianthus Capital Holdings Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
How much is Ianthus worth?
$11.26MiAnthus Capital Holdings Inc.Volume97.05KMarket Value$11.26MShares Outstanding171.72MEPS (TTM)-$0.3896P/E Ratio (TTM)N/A7 more rows
Is acreage holdings publicly traded?
Acreage had its initial public offering in November 2018, beginning trading on the Canadian Securities Exchange.
How has iAnthus Capital's stock performed in 2022?
iAnthus Capital's stock was trading at $0.0980 at the beginning of the year. Since then, ITHUF shares have decreased by 26.0% and is now trading at...
Are investors shorting iAnthus Capital?
iAnthus Capital saw a decline in short interest during the month of May. As of May 31st, there was short interest totaling 6,800 shares, a decline...
Who are iAnthus Capital's key executives?
iAnthus Capital's management team includes the following people: Mr. Robert R. Galvin , Interim CEO, Interim COO, Sr. VP, Chief Admin. Officer &...
Who are some of iAnthus Capital's key competitors?
Some companies that are related to iAnthus Capital include Abacus Health Products (ABAHF) , Acreage (ACRGF) , Alliance Growers (ACGWF) , Althea...
What is iAnthus Capital's stock symbol?
iAnthus Capital trades on the OTCMKTS under the ticker symbol "ITHUF."
How do I buy shares of iAnthus Capital?
Shares of ITHUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
What is iAnthus Capital's stock price today?
One share of ITHUF stock can currently be purchased for approximately $0.07.
How many employees does iAnthus Capital have?
iAnthus Capital employs 930 workers across the globe.
What is iAnthus Capital's official website?
The official website for iAnthus Capital is www.ianthuscapital.com .
About iAnthus Capital
iAnthus Capital (OTCMKTS:ITHUF) Frequently Asked Questions
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States.
Stocks in play: iAnthus Capital Holdings Inc
iAnthus Capital's stock was trading at $0.5282 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, ITHUF stock has decreased by 74.4% and is now trading at $0.1350. View which stocks have been most impacted by COVID-19.
iAnthus Closes Acquisition of New Jersey License Holder
Announced the closing of its acquisition of 100% of the equity interests of MPX New Jersey, LLC, a medical ...
iAnthus Announces Resignation of Director
iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTC: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, announces the closing of its acquisition of 100% of the equity interests of MPX New Jersey, LLC ("MPX NJ"), a medical cannabis permit holder in New Jersey.
0.0 Analyst's Opinion
iAnthus Capital Holdings, Inc. ("iAnthus" or the "Company") (CSE: IAN) (OTCPK: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, announces the resignation of Robert M. Whelan, Jr. from its Board of Directors. Mr.
Is iAnthus Capital a buy right now?
iAnthus Capital has received 29 “outperform” votes. (Add your “outperform” vote.)
When is iAnthus Capital's next earnings date?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iAnthus Capital in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" iAnthus Capital stock.
What other stocks do shareholders of iAnthus Capital own?
iAnthus Capital is scheduled to release its next quarterly earnings announcement on Thursday, April 7th 2022. View our earnings forecast for iAnthus Capital.
What is iAnthus Capital's stock symbol?
Based on aggregate information from My MarketBeat watchlists, some companies that other iAnthus Capital investors own include Aphria (APHA), MPX International (MPXOF), Emerald Health Therapeutics (EMH), OrganiGram (OGI), HEXO (HEXO), Netflix (NFLX), Albemarle (ALB), Brookfield Property Partners (BPY), CVS Health (CVS) and Supreme Cannabis (FIRE).
How do I buy shares of iAnthus Capital?
iAnthus Capital trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IAN."
Transparency is our policy. Learn how it impacts everything we do
Shares of IAN and other Canadian stocks can be purchased through an online brokerage account.
How we make money
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
How we use your personal data
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management.
How we approach editorial content
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
